Volume 27, supplement 1, Mars 2021

Éditorial

Éditorial (p.3-4)
Thierry Lamy de la Chapelle
Free Access

Revues

Prognostic factors in diffuse large B-cell lymphoma at diagnosis (international prognostic index excluded) (p.5-17)
Julien Calvani, Véronique Meignin, Laëtitia Vercellino, Catherine Thieblemont
Free Access

How to optimize the evaluation of the therapeutic response in patients with diffuse large B cell lymphoma on the first line (p.18-25)
Fabrice Jardin
Free Access

Immune therapy for relapsed or refractory diffuse large B cell lymphomas (p.26-36)
Jean Lemoine, Roch Houot
Free Access

Targeted therapies in diffuse large B-cell lymphomas (p.37-50)
Maxime Jullien, Steven Le Gouill
Free Access